Dalgleish Centre Myeloma Research Forum: From Benchtop to Bedside

Name: Dalgleish Centre Myeloma Research Forum: From Benchtop to Bedside
Start: 2024-11-08T12:00:35+1100
End: 2024-11-08T15:00:00+1100
Location: HYBRID EVENT

Fri, 8 Nov 2024, 12pm - 3pm AEDT

HYBRID EVENT

The Barrie Dalgleish Centre

66 followers · Contact host

Description

Interested in learning more about research into multiple myeloma? Wondering about the different types of research and how it all fits together?

Join us for an afternoon of talks and Q&A with our panel of researchers, clinicians, and people whose lives have been affected by myeloma and have your questions answered. Learn about our current research and how we are finding better ways to diagnose and treat myeloma, and take a tour of our research facilities.

Attendance is free whether online or in-person, but please register to let us know you're coming. (Note that facility tours are available for in-person attendees only.)

We hope to see you there!

Tickets for good, not greed Humanitix dedicates 100% of profits from booking fees to charity

Host information

The Barrie Dalgleish Centre

66 followers

Contact host

View profile

Multiple myeloma (MM), a malignancy of plasma cells that develops within the bone marrow, represents the second most frequently diagnosed form of blood cancer. Despite major therapeutic progress in the last two decades, MM is generally considered incurable with currently available standard of care treatments. This year around 2,600 Australians will be diagnosed with myeloma and this cancer, which affects white blood cells, will claim 1,100 lives. The chance of survival after five years is currently 55%.

The Barrie Dalgleish Centre for Myeloma and Related Blood Cancers harnesses the collective human talent, resources and equipment from across Peter Mac and our partner organisations to enhance our knowledge of the biological and molecular causes of multiple myeloma, develop new diagnostic and therapeutic options, and ultimately put in place new treatment modalities for patients. Partners include WEHI, University of Melbourne, Royal Melbourne Hospital, St Vincent’s Medical Research Institute and St Vincent’s Hospital.

The Centre’s mission is to make new discoveries in multiple myeloma research that will lead to translatable outcomes important not just for multiple myeloma, but for other types of blood cancers.